References
- Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71
- Globocan 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=lung [Last accessed 10 October 2016]
- CRUK statistics. Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival#heading-Zero [Last accessed 10 October 2016]
- SEER database. Available at: http://seer.cancer.gov/csr/1975_2013/ [Last accessed 10 October 2016]
- Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-17
- Abdel-Rahman O. Targeting the MEK signaling pathway in non-small cell lung cancer (NSCLC) patients with RAS aberrations. Ther Adv Respir Dis 2016;10:265-74
- Malvezzi M, Bertuccio P, Rosso T, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol 2015;26:779-86
- Hirayama T. The problem of smoking and lung cancer in Japan with special reference to the rising trend in age-specific mortality rate by number of cigarettes smoked daily. Jpn J Cancer Res 1987;78:203-10
- Colzani E, Liljegren A, Johansson ALV, et al. Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 2011;29:4014-21
- Surveillance, Epidemiology and End Results Program. About the SEER Program. Available at: http://seer.cancer.gov/about [Last accessed 25 June 2016]
- NCI cancer terms dictionary. Available at: https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid = 655264 [Last accessed 28 November 2016]
- Hubbard MO, Fu P, Margevicius S, et al. Five-year survival does not equal cure in non–small cell lung cancer: a Surveillance, Epidemiology, and End Results–based analysis of variables affecting 10- to 18-year survival. J Thorac Cardiovasc Surg 2012;143:1307-13
- Lin SH, Zhang N, Godby J, et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer 2016;122:917-28
- Park HS, Harder EM, Mancini BR, Decker RH. Central versus peripheral tumor location: influence on survival, local control, and toxicity following stereotactic body radiotherapy for primary non-small-cell lung cancer. J Thorac Oncol 2015;10:832-7
- Park CH, Bonomi M, Cesaretti J, et al. Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys 2011;81:706-11
- Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-65
- Jolly S, Vittinghoff E, Chattopadhyay A, Bibbins-Domingo K. Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med 2010;123:811-18
- Maas A, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J 2010;18:598-602
- Rivera MP. Lung cancer in women: differences in epidemiology, biology, histology, and treatment outcomes. Semin Respir Crit Care Med 2013;34:792-801
- Lally BE, Detterbeck FC, Geiger AM, et al. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer 2007;110:911-17
- Kravchenko J, Berry M, Arbeev K, et al. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Canc 2015;88:85-93
- Halanych JH, Shuaib F, Parmar G, et al. Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Epidemiol 2011;173:1319-26
- Kochanek KD, Murphy SL, Xu JQ, Tejada-Vera B. Deaths: Final Data for 2014. Natl Vital Stat Rep 2016;65
- Donin N, Filson C, Drakaki A, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016;122:3075-86